Advertisement
Advances in Pediatrics

Advances in Pediatric Pharmacology, Therapeutics, and Toxicology

      The field of pediatric pharmacology, therapeutics, and toxicology has continued to show marked advancement, and this article highlights many of the tremendous discoveries that have occurred between July 2006 and June 2009. While new therapies and management strategies have been developed, many commonly used drugs and paradigms have been challenged. These aspects include the scrutiny involving over-the-counter (OTC) cough and cold medications and pain relievers, challenges to the routine use of antibiotics for endocarditis and vesicourethral reflux prophylaxis, and controversies over the safety of and monitoring requirements for stimulant medication use for children with attention-deficit/hyperactivity disorder (ADHD).
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Advances in Pediatrics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

      1. 110th Congress. Food and Drug Administration Amendments Act of 2007. Public Law 110–85. September 27, 2007.

        • Rodriguez W.
        • Selen A.
        • Avant D.
        • et al.
        Improving pediatric dosing through pediatric initiatives: what we have learned.
        Pediatrics. 2008; 121: 530-539
        • Johnson T.N.
        The problems in scaling adult drug doses to children.
        Arch Dis Child. 2008; 93: 207-211
        • Hawcutt D.B.
        • Smyth R.L.
        One size does not fit all: getting drug doses right for children.
        Arch Dis Child. 2008; 93: 190-191
        • US Food and Drug Administration
        Drugs to which FDA has granted pediatric exclusivity for pediatric studies under section 505A of the Federal Food, Drug, and Cosmetic Act.
        (Available at:) (Accessed July 10, 2009)
        • Kearns G.L.
        • Ritschel W.A.
        • Wilson J.T.
        • et al.
        Clinical pharmacology: a discipline called to action for maternal and child health.
        Clin Pharmacol Ther. 2007; 81: 463-468
        • AAP Department of Research
        Investigation finds limited capacity to conduct pediatric drug trials.
        AAP News. 2008; 29: 12
        • Smith S.M.
        • Schroeder K.
        • Fahey T.
        Over-the-counter medications for acute cough in children and adults in ambulatory settings.
        Cochrane Database Syst Rev. 2008; (CD001831)
        • Shields M.D.
        • Bush A.
        • Everard M.L.
        • et al.
        BTS guidelines: recommendations for the assessment and management of cough in children.
        Thorax. 2008; 63: iii1-iii15
        • Vernacchio L.
        • Kelly J.P.
        • Kaufman D.W.
        • et al.
        Cough and cold medication use by US children, 1999–2006: results from the Slone survey.
        Pediatrics. 2008; 122: e323-e329
      2. 109th Congress. USA Patriot Improvement and Reauthorization Act of 2005. Public Law 109–177. March 9, 2006.

        • Vernacchio L.
        • Kelly J.P.
        • Kaufman D.W.
        • et al.
        Pseudoephedrine use among US children, 1999–2006: results from the Slone survey.
        Pediatrics. 2008; 122: 1299-1304
        • Hendeles L.
        • Hatton R.C.
        Oral phenylephrine: an ineffective replacement for pseudoephedrine?.
        J Allergy Clin Immunol. 2006; 118: 279-280
      3. Infant deaths associated with cough and cold medications—two states, 2005.
        MMWR Morb Mortal Wkly Rep. 2007; 56: 1-4
      4. (Available at:) (Accessed July 12, 2009)
      5. (Available at:) (Accessed July 13, 2009)
        • Sharfstein J.M.
        • North M.
        • Serwint J.R.
        Over the counter but no longer under the radar—pediatric cough and cold medications.
        N Engl J Med. 2007; 357: 2321-2324
        • Kuehn B.M.
        Citing serious risks, FDA recommends no cold and cough medicines for infants.
        JAMA. 2008; 299: 887-888
      6. (Available at:) (Accessed July 14, 2009)
        • Paul I.M.
        • Beiler J.
        • McMonagle A.
        • et al.
        Effect of honey, dextromethorphan, and no treatment on nocturnal cough and sleep quality for coughing children and their parents.
        Arch Pediatr Adolesc Med. 2007; 161: 1140-1146
        • Slapak I.
        • Skoupa J.
        • Strnad P.
        • et al.
        Efficacy of isotonic nasal wash (seawater) in the treatment and prevention of rhinitis in children.
        Arch Otolaryngol Head Neck Surg. 2008; 134: 67-74
        • Schaefer M.K.
        • Shehab N.
        • Cohen A.L.
        • et al.
        Adverse events from cough and cold medications in children.
        Pediatrics. 2008; 121: 783-787
        • Dart R.C.
        • Paul I.M.
        • Bond G.R.
        • et al.
        Pediatric fatalities associated with over the counter (nonprescription) cough and cold medications.
        Ann Emerg Med. 2009; 53: 411-417
        • Lokker N.
        • Sanders L.
        • Perrin E.M.
        • et al.
        Parental misinterpretations of over-the-counter pediatric cough and cold medication labels.
        Pediatrics. 2009; 123: 1464-1471
        • Kuehn B.M.
        Debate continues over the safety of cold and cough medicines for children.
        JAMA. 2008; 300: 2354-2356
      7. (Available at:) (Accessed July 11, 2009)
        • Mitka M.
        FDA bans sale of unapproved cough suppressants containing hydrocodone.
        JAMA. 2007; 298: 2251-2252
      8. (Available at:) (Accessed July 9, 2009)
      9. (Available at:) (Accessed July 10, 2009)
        • Hay A.D.
        • Costelloe C.
        • Redmond N.M.
        • et al.
        Paracetamol plus ibuprofen for the treatment of fever in children (PITCH): randomised controlled trial.
        BMJ. 2008; 337: a1302
        • Kramer L.C.
        • Richards P.A.
        • Thompson A.M.
        • et al.
        Alternating antipyretics: antipyretic efficacy of acetaminophen versus acetaminophen alternated with ibuprofen in children.
        Clin Pediatr (Phila). 2008; 47: 907-911
        • Clark E.
        • Plint A.C.
        • Correll R.
        • et al.
        A randomized, controlled trial of acetaminophen, ibuprofen, and codeine for acute pain relief in children with musculoskeletal trauma.
        Pediatrics. 2007; 119: 460-467
        • Rovers M.M.
        • Glasziou P.
        • Appelman C.L.
        • et al.
        Antibiotics for acute otitis media: a meta-analysis with individual patient data.
        Lancet. 2006; 368: 1429-1435
        • Koopman L.
        • Hoes A.W.
        • Glasziou P.P.
        • et al.
        Antibiotic therapy to prevent the development of asymptomatic middle ear effusion in children with acute otitis media: a meta-analysis of individual patient data.
        Arch Otolaryngol Head Neck Surg. 2008; 134: 128-132
        • Spiro D.M.
        • Tay K.Y.
        • Arnold D.H.
        • et al.
        Wait-and-see prescription for the treatment of acute otitis media: a randomized controlled trial.
        JAMA. 2006; 296: 1235-1241
        • van der Veen E.L.
        • Rovers M.M.
        • Albers F.W.
        • et al.
        Effectiveness of trimethoprim/sulfamethoxazole for children with chronic active otitis media: a randomized, placebo-controlled trial.
        Pediatrics. 2007; 119: 897-904
        • Schwartz R.H.
        Once-daily ofloxacin otic solution versus neomycin sulfate/polymyxin B sulfate/hydrocortisone otic suspension four times a day: a multicenter, randomized, evaluator-blinded trial to compare the efficacy, safety, and pain relief in pediatric patients with otitis externa.
        Curr Med Res Opin. 2006; 22: 1725-1736
        • Roland P.S.
        • Smith T.L.
        • Schwartz S.R.
        • et al.
        Clinical practice guideline: cerumen impaction.
        Otolaryngol Head Neck Surg. 2008; 139: S1-S21
        • Wallace D.V.
        • Dykewicz M.S.
        • Bernstein D.I.
        • et al.
        The diagnosis and management of rhinitis: an updated practice parameter.
        J Allergy Clin Immunol. 2008; 122: S1-84
        • Section on Pediatric Pulmonology, Subcommittee on Obstructive Sleep Apnea Syndrome. American Academy of Pediatrics
        Clinical practice guideline: diagnosis and management of childhood obstructive sleep apnea syndrome.
        Pediatrics. 2002; 109: 704-712
        • Kheirandish-Gozal L.
        • Gozal D.
        Intranasal budesonide treatment for children with mild obstructive sleep apnea syndrome.
        Pediatrics. 2008; 122: e149-e155
        • Clegg H.W.
        • Ryan A.G.
        • Dallas S.D.
        • et al.
        Treatment of streptococcal pharyngitis with once-daily compared with twice-daily amoxicillin: a noninferiority trial.
        Pediatr Infect Dis J. 2006; 25: 761-767
        • Lennon D.R.
        • Farrell E.
        • Martin D.R.
        • et al.
        Once-daily amoxicillin versus twice-daily penicillin V in group A beta-haemolytic streptococcal pharyngitis.
        Arch Dis Child. 2008; 93: 474-478
        • National Asthma Education and Prevention Program Expert Panel Report 3
        Guidelines for the diagnosis and management of Asthma.
        U.S. Department of Health and Human Services, National Institute of Health, National Heart Lung and Blood Institute, 2007 (Available at:) (Accessed July 10, 2009)
        • Panickar J.
        • Lakhanpaul M.
        • Lambert P.C.
        • et al.
        Oral prednisolone for preschool children with acute virus-induced wheezing.
        N Engl J Med. 2009; 360: 329-338
        • Ducharme F.M.
        • Lemire C.
        • Noya F.J.
        • et al.
        Preemptive use of high-dose fluticasone for virus-induced wheezing in young children.
        N Engl J Med. 2009; 360: 339-353
        • Bacharier L.B.
        • Phillips B.R.
        • Zeiger R.S.
        • et al.
        Episodic use of an inhaled corticosteroid or leukotriene receptor antagonist in preschool children with moderate-to-severe intermittent wheezing.
        J Allergy Clin Immunol. 2008; 122 (e8): 1127-1135
        • American Academy of Pediatrics Subcommittee on Diagnosis and Management of Bronchiolitis
        Diagnosis and management of bronchiolitis.
        Pediatrics. 2006; 118: 1774-1793
        • Corneli H.M.
        • Zorc J.J.
        • Mahajan P.
        • et al.
        A multicenter, randomized, controlled trial of dexamethasone for bronchiolitis.
        N Engl J Med. 2007; 357: 331-339
        • Plint A.C.
        • Johnson D.W.
        • Patel H.
        • et al.
        Epinephrine and dexamethasone in children with bronchiolitis.
        N Engl J Med. 2009; 360: 2079-2089
        • Scheffler R.M.
        • Brown T.T.
        • Fulton B.D.
        • et al.
        Positive association between attention-deficit/hyperactivity disorder medication use and academic achievement during elementary school.
        Pediatrics. 2009; 123: 1273-1279
        • Arnold L.E.
        • Lindsay R.L.
        • Lopez F.A.
        • et al.
        Treating attention-deficit/hyperactivity disorder with a stimulant transdermal patch: the clinical art.
        Pediatrics. 2007; 120: 1100-1106
        • Scahill L.
        Alpha-2 adrenergic agonists in attention deficit hyperactivity disorder.
        J Pediatr. 2009; 154: S32-S37
        • Biederman J.
        • Melmed R.D.
        • Patel A.
        • et al.
        A randomized, double-blind, placebo-controlled study of guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder.
        Pediatrics. 2008; 121: e73-e84
        • Weber W.
        • Vander Stoep A.
        • McCarty R.L.
        • et al.
        Hypericum perforatum (St John’s wort) for attention-deficit/hyperactivity disorder in children and adolescents: a randomized controlled trial.
        JAMA. 2008; 299: 2633-2641
        • Vetter V.L.
        • Elia J.
        • Erickson C.
        • et al.
        Cardiovascular monitoring of children and adolescents with heart disease receiving stimulant drugs: a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young Congenital Cardiac Defects Committee and the Council on Cardiovascular Nursing.
        Circulation. 2008; 117: 2407-2423
        • Perrin J.M.
        • Friedman R.A.
        • Knilans T.K.
        Cardiovascular monitoring and stimulant drugs for attention-deficit/hyperactivity disorder.
        Pediatrics. 2008; 122: 451-453
        • Hampton T.
        Group’s advice on cardiac testing for children with ADHD draws criticism.
        JAMA. 2008; 299: 2735
      10. (Available at:) (Accessed July 19, 2009)
        • Gould M.S.
        • Walsh B.T.
        • Munfakh J.L.
        • et al.
        Sudden death and use of stimulant medications in youths.
        Am J Psychiatry. 2009; 166: 992-1001
      11. (Available at:) (Accessed July 5, 2009)
        • Kurian B.T.
        • Ray W.A.
        • Arbogast P.G.
        • et al.
        Effect of regulatory warnings on antidepressant prescribing for children and adolescents.
        Arch Pediatr Adolesc Med. 2007; 161: 690-696
        • Bridge J.A.
        • Iyengar S.
        • Salary C.B.
        • et al.
        Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials.
        JAMA. 2007; 297: 1683-1696
        • Brent D.
        • Emslie G.
        • Clarke G.
        • et al.
        Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: the TORDIA randomized controlled trial.
        JAMA. 2008; 299: 901-913
        • Walkup J.T.
        • Albano A.M.
        • Piacentini J.
        • et al.
        Cognitive behavioral therapy, sertraline, or a combination in childhood anxiety.
        N Engl J Med. 2008; 359: 2753-2766
      12. (Available at:) (Accessed July 5, 2009)
        • McIntyre R.S.
        • Jerrell J.M.
        Metabolic and cardiovascular adverse events associated with antipsychotic treatment in children and adolescents.
        Arch Pediatr Adolesc Med. 2008; 162: 929-935
        • Myers S.M.
        • Johnson C.P.
        Management of children with autism spectrum disorders.
        Pediatrics. 2007; 120: 1162-1182
        • Blumer J.L.
        • Reed M.D.
        • Steinberg F.
        • et al.
        Potential pharmacokinetic basis for zolpidem dosing in children with sleep difficulties.
        Clin Pharmacol Ther. 2008; 83: 551-558
        • Wilson W.
        • Taubert K.A.
        • Gewitz M.
        • et al.
        Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group.
        Circulation. 2007; 116: 1736-1754
        • Liberman J.N.
        • Berger J.E.
        • Lewis M.
        Prevalence of antihypertensive, antidiabetic, and dyslipidemic prescription medication use among children and adolescents.
        Arch Pediatr Adolesc Med. 2009; 163: 357-364
        • Flynn J.T.
        • Daniels S.R.
        Pharmacologic treatment of hypertension in children and adolescents.
        J Pediatr. 2006; 149: 746-754
        • Belay B.
        • Belamarich P.F.
        • Tom-Revzon C.
        The use of statins in pediatrics: knowledge base, limitations, and future directions.
        Pediatrics. 2007; 119: 370-380
        • Conway P.H.
        • Cnaan A.
        • Zaoutis T.
        • et al.
        Recurrent urinary tract infections in children: risk factors and association with prophylactic antimicrobials.
        JAMA. 2007; 298: 179-186
        • Montini G.
        • Rigon L.
        • Zucchetta P.
        • et al.
        Prophylaxis after first febrile urinary tract infection in children? A multicenter, randomized, controlled, noninferiority trial.
        Pediatrics. 2008; 122: 1064-1071
        • Pennesi M.
        • Travan L.
        • Peratoner L.
        • et al.
        Is antibiotic prophylaxis in children with vesicoureteral reflux effective in preventing pyelonephritis and renal scars? A randomized, controlled trial.
        Pediatrics. 2008; 121: e1489-e1494
        • Committee on Infectious Diseases
        The use of systemic fluoroquinolones.
        Pediatrics. 2006; 118: 1287-1292
      13. (Available at:) (Accessed December 30, 2009)
        • American Academy of Pediatrics Committee on Infectious Diseases
        Antiviral therapy and prophylaxis for influenza in children.
        Pediatrics. 2007; 119: 852-860
        • Elliott D.J.
        • Zaoutis T.E.
        • Troxel A.B.
        • et al.
        Empiric antimicrobial therapy for pediatric skin and soft-tissue infections in the era of methicillin-resistant Staphylococcus aureus.
        Pediatrics. 2009; 123: e959-e966
        • Hersh A.L.
        • Maselli J.H.
        • Cabana M.D.
        Changes in prescribing of antiviral medications for influenza associated with new treatment guidelines.
        Am J Public Health. 2009; 99: S362-S364
      14. (Available at:) (Accessed December 30, 2009)
      15. (Available at:) (Accessed December 30, 2009)
        • DeCamp L.R.
        • Byerley J.S.
        • Doshi N.
        • et al.
        Use of antiemetic agents in acute gastroenteritis: a systematic review and meta-analysis.
        Arch Pediatr Adolesc Med. 2008; 162: 858-865
      16. (Available at:) (Accessed December 31, 2009)
        • Khoshoo V.
        • Edell D.
        • Thompson A.
        • et al.
        Are we overprescribing antireflux medications for infants with regurgitation?.
        Pediatrics. 2007; 120: 946-949
        • Hibbs A.M.
        • Lorch S.A.
        Metoclopramide for the treatment of gastroesophageal reflux disease in infants: a systematic review.
        Pediatrics. 2006; 118: 746-752
        • Bahar R.J.
        • Collins B.S.
        • Steinmetz B.
        • et al.
        Double-blind placebo-controlled trial of amitriptyline for the treatment of irritable bowel syndrome in adolescents.
        J Pediatr. 2008; 152: 685-689
        • Marson A.G.
        • Al-Kharusi A.M.
        • Alwaidh M.
        • et al.
        The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial.
        Lancet. 2007; 369: 1016-1026
        • Marson A.G.
        • Al-Kharusi A.M.
        • Alwaidh M.
        • et al.
        The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial.
        Lancet. 2007; 369: 1000-1015
        • Steering Committee on Quality Improvement and Management, Subcommittee on Febrile Seizures American Academy of Pediatrics
        Febrile seizures: clinical practice guideline for the long-term management of the child with simple febrile seizures.
        Pediatrics. 2008; 121: 1281-1286
        • Lewis D.
        • Winner P.
        • Saper J.
        • et al.
        Randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of topiramate for migraine prevention in pediatric subjects 12 to 17 years of age.
        Pediatrics. 2009; 123: 924-934
        • Lewis D.W.
        • Winner P.
        • Hershey A.D.
        • et al.
        Efficacy of zolmitriptan nasal spray in adolescent migraine.
        Pediatrics. 2007; 120: 390-396
        • Pope E.
        • Krafchik B.R.
        • Macarthur C.
        • et al.
        Oral versus high-dose pulse corticosteroids for problematic infantile hemangiomas: a randomized, controlled trial.
        Pediatrics. 2007; 119: e1239-e1247
        • Leaute-Labreze C.
        • Dumas de la Roque E.
        • Hubiche T.
        • et al.
        Propranolol for severe hemangiomas of infancy.
        N Engl J Med. 2008; 358: 2649-2651
        • Inoue Y.
        • Okada Y.
        • Shinohara M.
        • et al.
        A multicenter prospective randomized trial of corticosteroids in primary therapy for Kawasaki disease: clinical course and coronary artery outcome.
        J Pediatr. 2006; 149: 336-341
        • Newburger J.W.
        • Sleeper L.A.
        • McCrindle B.W.
        • et al.
        Randomized trial of pulsed corticosteroid therapy for primary treatment of Kawasaki disease.
        N Engl J Med. 2007; 356: 663-675
        • Lovell D.J.
        • Ruperto N.
        • Goodman S.
        • et al.
        Adalimumab with or without methotrexate in juvenile rheumatoid arthritis.
        N Engl J Med. 2008; 359: 810-820
        • Vazquez-Cobian L.B.
        • Flynn T.
        • Lehman T.J.
        Adalimumab therapy for childhood uveitis.
        J Pediatr. 2006; 149: 572-575
        • Ruperto N.
        • Lovell D.J.
        • Quartier P.
        • et al.
        Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trial.
        Lancet. 2008; 372: 383-391
        • Yokota S.
        • Imagawa T.
        • Mori M.
        • et al.
        Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial.
        Lancet. 2008; 371: 998-1006
      17. (Available at:) (Accessed December 31, 2009)
        • Louik C.
        • Lin A.E.
        • Werler M.M.
        • et al.
        First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects.
        N Engl J Med. 2007; 356: 2675-2683
        • Ferreira E.
        • Carceller A.M.
        • Agogue C.
        • et al.
        Effects of selective serotonin reuptake inhibitors and venlafaxine during pregnancy in term and preterm neonates.
        Pediatrics. 2007; 119: 52-59
        • Oberlander T.F.
        • Reebye P.
        • Misri S.
        • et al.
        Externalizing and attentional behaviors in children of depressed mothers treated with a selective serotonin reuptake inhibitor antidepressant during pregnancy.
        Arch Pediatr Adolesc Med. 2007; 161: 22-29
        • Meador K.J.
        • Baker G.A.
        • Browning N.
        • et al.
        Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs.
        N Engl J Med. 2009; 360: 1597-1605